Quaker Chemical (NYSE: KWR) EVP exercises options and sells 731 common shares

Rhea-AI Filing Summary

Quaker Chemical Corp EVP Jeewat Bijlani reported an option exercise and related share sale. On 2026-05-26, he exercised employee stock options for 731 shares of common stock at $136.64 per share and sold 731 shares in an open-market transaction at a weighted average price of $145.7678 per share. Following these transactions, he held 6,748 shares of common stock directly and 62 shares indirectly through a 401(k) plan.

Insider Trade Summary

Net Seller: 731 shares ($106,556)

Net Sell 4 txns

Insider Bijlani Jeewat

Role EVP, Glob. Spec. & CGO

Sold 731 shs ($107K)

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	731	$0.00	--
Exercise	Common Stock	731	$136.64	$100K
Sale	Common Stock	731	$145.7678	$107K
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 0 shares (Direct, null); Common Stock — 7,479 shares (Direct, null); Common Stock — 62 shares (Indirect, By 401(k))

Footnotes (1)

1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.65 to $145.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Information based on reporting person's Plan Statement as of March 31, 2026. The options for this grant vested in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.

Key Figures

Shares sold: 731 shares Weighted average sale price: $145.7678 per share Options exercised: 731 shares +4 more

7 metrics

Shares sold 731 shares Open-market sale of common stock on May 26, 2026

Weighted average sale price $145.7678 per share Common stock sale on May 26, 2026

Options exercised 731 shares Employee Stock Option exercise on May 26, 2026

Option exercise price $136.64 per share Conversion or exercise price for Employee Stock Option

Direct holdings after transactions 6,748 shares Common stock directly owned after May 26, 2026 transactions

Indirect 401(k) holdings 62 shares Common stock held via 401(k) based on March 31, 2026 plan statement

Net buy/sell shares -731 shares Net share change from buy/sell activity in transaction summary

Key Terms

Employee Stock Option (right to buy), open-market sale, weighted average sale price, Plan Statement, +2 more

6 terms

Employee Stock Option (right to buy) financial

"security_title": "Employee Stock Option (right to buy)""

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

Plan Statement financial

"Information based on reporting person's Plan Statement as of March 31, 2026."

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

vested in three annual installments financial

"The options for this grant vested in three annual installments"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bijlani Jeewat

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428-2380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Glob. Spec. & CGO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/26/2026		M		731	A	$136.64	7,479	D
Common Stock	05/26/2026		S		731	D	$145.7678(1)	6,748	D
Common Stock								62(2)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$136.64	05/26/2026		M			731	(3)	03/30/2027	Common Stock	731	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.65 to $145.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

2. Information based on reporting person's Plan Statement as of March 31, 2026.

3. The options for this grant vested in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Jeewat Bijlani	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did KWR executive Jeewat Bijlani report on May 26, 2026?

Jeewat Bijlani reported exercising employee stock options for 731 Quaker Chemical common shares at $136.64 and selling 731 shares in an open-market transaction at a weighted average price of $145.7678, all dated May 26, 2026.

At what prices did KWR executive Jeewat Bijlani exercise and sell shares?

He exercised options at a strike price of $136.64 per share and sold 731 Quaker Chemical common shares at a weighted average sale price of $145.7678, with individual sale prices ranging from $145.65 to $145.88 per share.

How many KWR shares does Jeewat Bijlani hold after the reported Form 4 transactions?

After the May 26, 2026 transactions, Jeewat Bijlani directly held 6,748 shares of Quaker Chemical common stock and indirectly held 62 shares through a 401(k) plan, based on his plan statement as of March 31, 2026.

What type of derivative security did KWR executive Jeewat Bijlani exercise?

He exercised an Employee Stock Option (right to buy) covering 731 Quaker Chemical common shares at a conversion or exercise price of $136.64 per share, and the option position for that grant was reduced to zero following the exercise.

Were Jeewat Bijlani’s KWR share sales made at a single price or multiple prices?

His 731 Quaker Chemical share sale used a weighted average price of $145.7678. Footnotes state the shares were sold in multiple transactions at prices ranging from $145.65 to $145.88 per share, and detailed breakdowns are available upon request.